Citation Impact
Citing Papers
Risk Factors for Venous Thromboembolism
2003 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia
2009
Parenteral Anticoagulants
2012 Standout
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia
2001
Heparin-Protein Interactions
2002 Standout
Mechanisms of Thrombus Formation
2008 Standout
Heparin-induced thrombocytopenia
1996
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Complications From Heparin-induced Thrombocytopenia in Patients Undergoing Cardiopulmonary Bypass
1993
Pediatric Heparin-Induced Thrombocytopenia: Prevalence, Thrombotic Risk, and Application of the 4Ts Scoring System
2014
Thrombocytopenia in the Intensive Care Unit
1993
Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognition
1992
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Heparin-induced thrombocytopenia
2000
Antithrombotic Therapy for VTE Disease
2016 Standout
Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia
2005
Heparin-Induced Thrombocytopenia
1998
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Pulmonary embolism after cardiac surgery
1993
Low-dose danaparoid sodium catheter flushes in an intensive care infant suffering from heparin-induced thrombocytopenia
2001
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
1999
Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin
1996
Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials
1998
Antithrombotic Therapy for VTE Disease
2012 Standout
Executive Summary
2012 Standout
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings
2006 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Platelets and the immune continuum
2011 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
The Cost-Effectiveness of Argatroban Treatment in Heparin-Induced Thrombocytopenia
2005
A 14-year study of heparin-induced thrombocytopenia
1996 Standout
Safety of Warfarin Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Heparin-Induced Thrombocytopenia
2004
Prevention of Venous Thromboembolism
2008 Standout
Antithrombotic Therapy in Neonates and Children
2008
Antithrombotic Therapy in Neonates and Children
2012
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
On the mechanisms of biocompatibility
2008 Standout
Catheter-related thrombosis in critically ill children: Comparison of catheters with and without heparin bonding
1995
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations
1998
Thrombocytopenia Associated with Antithrombotic Therapy in Patients with Cardiovascular Diseases
2008
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
2013 Standout
A Rapid and Sensitive Test for Diagnosing Heparin-Associated Thrombocytopenia
1991
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]
1991
Fondaparinux: A potential new therapy for HIT
2005
Heparin-Induced Thrombocytopenia Screening and Management in Pediatric Patients
2011
State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome
1998
Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass Surgery
1997
Heparin-induced Thrombocytopenia Type II in Subarachnoid Hemorrhage Patients: Incidence and Complications
2005
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Delayed-Onset Heparin-Induced Thrombocytopenia
2002
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Surgical management of heparin-associated thrombocytopenia
1988
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters
2008
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Low-Molecular-Weight Heparins
1997 Standout
Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism.
1988
Heparin-induced thrombocytopenia
2004
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
1992
Anticoagulants and Thrombolytics
1991
Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 Cases
1995
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Central venous catheter use
2001
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effect of Heparin-bonded Central Venous Catheters on the Incidence of Catheter-related Thrombosis and Infection in Children and Adults
2006
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass
1991
Osmolality Changes during Hemodialysis
1977
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition ‐ Annex: List of Products
2005 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of Jerry Laster being referenced
Heparin-induced thrombocytopenia in the newborn
1992
Reexposure to heparin of patients with heparin-associated antibodies
1989
Reexposure to heparin of patients with heparin-associated antibodies
1989
Heparin-coated catheters and heparin-induced thrombocytopenia
1988
The heparin-induced thrombocytopenia syndrome
1988
Increased intracranial pressure from unsustained levels of plasma mannitol during hemodialysis.
1967
Heparin-induced thrombocytopenia in the newborn
1992
The heparin-induced thrombocytopenia syndrome: an update.
1987
Thrombocytopenia Associated With Heparin-Coated Catheters in Patients With Heparin-Associated Antiplatelet Antibodies
1989